Navigation Links
BioMS Medical to present at BIO CEO & Investor Conference
Date:2/8/2008

Toronto Stock Exchange Symbol: MS

EDMONTON, Feb. 8 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Kevin Giese, President and CEO, will present at the BIO CEO & Investor Conference 2008 in New York.

WHEN: Tuesday February 12th at 11:45 am (Eastern Time)

WHERE: Waldorf Astoria Hotel, New York

About BIO CEO & Investor Conference

-----------------------------------

The objective of the conference is to bring together institutional investors, industry analysts, and senior biotechnology executives in a neutral and collaborative forum to examine investment opportunities and issues affecting the industry. For more information visit: http://ceo.bio.org/opencms/ceo/2008/index.jsp

About BioMS Medical Corp.

-------------------------

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. For further information please visit our website at http://www.biomsmedical.com.

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such f
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
2. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
3. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
4. BioMS Medical announces third quarter 2007 results
5. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
6. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
7. BioMS Medical to present at BioContact 2007
8. BioMS Medical announces its intention to renew a normal course issuer bid
9. Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
10. Linc Facility Services Acquires Morse Medical
11. Perrigo Company to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...wire/--TwomoreprestigiousuniversitieshavejoinedBio...reerssiteforlifescienceprofessionals. ,, Northw...ard,joining28othermajorlifesciencetrainingInstitut...isonlyforpost-graduatesinthelifesciences.Whilether...BioCareerCenteristheonlyonethatserveslifesciencepo...
(Date:11/24/2009)...RNewswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq:...heNasdaqStockMarketthattradinginthecompany,scommon...-NSEwillbefiledwiththe,SecuritiesandExchangeCommis...gonNasdaq,unlessthecompanyfilesanappealtotheNasdaq...anappeal,which,willstaythesuspensionanddelistingth...
(Date:11/24/2009)... employment grew by 29,000 jobs in October, and t...rowth during the U.S. recession. However, clinics ...lth systems are coming closer to having to actuall...ators. , (Vocus) November...ing in October despite the shedding of jobs in mos...
(Date:11/24/2009)...a/--NODPharmaceuticalsInc.announced,theUSPatent&am...onfor,itsnano-particleoraldeliveryorNODtechnology....ncorporatepeptidesor,proteinsintobio-adhesivenano-...nisteredasinjections.NODtechnologyisaplatformtechn...hasinsulin,interferon,growthhormone,exenatide,hep...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...08 -- -- 3Q08 Net Income Increased 38% to...versus 3Q07 Diluted EPS $0.16 --, NEW YORK, Nov. ...tal,Bioengineering, Inc. (NYSE: AOB ), a pharmace...gh the development, manufacture and commercializat...counter ("OTC") products in,China, today announced...
...ulles Airport Capital Partners will provide partne...ortunities. , Dubai, Unit...d Trade Center Dulles Airport Capital Partners, an...vestors seeking to access global markets, today an...ters Association General Assembly in Dubai, United...
...Plasma & Materials Processing (PMP) of Eindhoven U...ve been awarded the Leverhulme Technology Transfer...ex and 63,000 for the research group) for their s...ia to industry. Earlier this year Hoex,s Ph.D. res...tein Award. , The TU/e-researchers were awarded f...
Other Biology Technology:American Oriental Bioengineering Reports Third Quarter 2008 Financial Results 2American Oriental Bioengineering Reports Third Quarter 2008 Financial Results 3American Oriental Bioengineering Reports Third Quarter 2008 Financial Results 4American Oriental Bioengineering Reports Third Quarter 2008 Financial Results 5American Oriental Bioengineering Reports Third Quarter 2008 Financial Results 6American Oriental Bioengineering Reports Third Quarter 2008 Financial Results 7American Oriental Bioengineering Reports Third Quarter 2008 Financial Results 8Former NASDAQ International President Among Execs Launching Firm to Access Global Markets 2Former NASDAQ International President Among Execs Launching Firm to Access Global Markets 3TU/e awarded for knowledge transfer to solar energy industry 2
(Date:11/24/2009)...search Institute (LRI) today named 12 new grant re...on, recognize innovative work across a broad spect... creativity, novelty, and potential to drive scien...cure the complex disease of systemic lupus. , Th... researchers across the nation and include interdi...
(Date:11/24/2009)...evel action of a remarkable class of ring-shaped p...th the Lawrence Berkeley National Laboratory (Berk...lography beamline at the Advanced Light Source (AL...e expression and replication, and are vital to the...ctious agents, such as the human papillomavirus, w...
(Date:11/24/2009)...tutes fish food is a matter of debate. A high-prof...almost 50 percent of their carbon from trees and l...terrestrial and aquatic ecosystems. , But new re...s is not likely to be true. Algae provide a much r...ing to research published this week in the Procee...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Spider Venom The Next Way to Treat Impotence 3F 58365 1Spider Venom The Next Way to Treat Impotence 3F 58365 2Infant pain adult repercussions 58363 1Infant pain adult repercussions 58363 2Infant pain adult repercussions 58363 3BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease 58361 1BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease 58361 2
...(February 26, 2009) It has been estimated that in ...ld stress annually, costing livestock producers m...rate need for effective mitigation strategies. Con...d researchers from the National Oceanic and Atmosp...st weather system advisory designed to improve the...
... -- For two weeks in March, some of the greatest n...llahassee to take part in public discussions on ho...ilosophy, history and the arts have shaped our und...sp of what lies ahead. , Titled "Origins ,09: Cel...-of-a-kind program was organized by the Office of ...
... Global climate rapidly shifted from a relatively...Antarctica about 34 million years ago. What happe...e geologists offers a new perspective on the natur...nhouse-to-icehouse transitionone that refutes earl...edicting future climate changes. , Detailed in th...
Other Biology News:How cold is too cold for newborn calves? 2World's top minds to celebrate 'the birth and life of beginnings' 2World's top minds to celebrate 'the birth and life of beginnings' 3World's top minds to celebrate 'the birth and life of beginnings' 4CO2 drop and global cooling caused Antarctic glacier to form 2
GIBCO Advanced D-MEM (Dulbecco's Modified Eagle Medium) (1X) liquid from Invitrogen
TNT T7 Coupled Wheat Germ Extract System from Promega
GIBCO Modified Eagle Medium (MEM) (2X); liquid from Invitrogen
Human Granulocyte Macrophage Colony Stimulating Factor, Unconjugated from PeproTech
Biology Products: